TY - JOUR
T1 - High prevalence of antibiotic resistance in nasopharyngeal bacterial isolates from healthy children in rural Uganda
T2 - A cross-sectional study
AU - Rutebemberwa, Elizeus
AU - Mpeka, Betty
AU - Pariyo, George
AU - Peterson, Stefan
AU - Mworozi, Edison
AU - Bwanga, Freddie
AU - Källander, Karin
N1 - Publisher Copyright:
© 2015 Taylor & Francis.
PY - 2015/10/2
Y1 - 2015/10/2
N2 - Background: In Uganda, the main causes of death in children under 5 years of age are malaria and pneumonia - often due to delayed diagnosis and treatment. In preparation for a community case management intervention for pneumonia and malaria, the bacterial composition of the nasopharyngeal flora and its in vitro resistance were determined in children aged five or under to establish baseline resistance to commonly used antibiotics. Methods: In a population-based survey in April 2008, nasopharyngeal specimens were collected from 152 randomly selected healthy children under 5 years of age in the Iganga/Mayuge Health and Demographic Surveillance Site (HDSS). Medical history and prior treatment were recorded. Demographic characteristics and risk factors for carriage of resistant strains were obtained from the HDSS census. Bacteria were isolated and analysed for antibiotic susceptibility using disk diffusion and E test. Results: Streptococcus pneumoniae (S. pneumoniae) carriage was 58.6%, and, while most (80.9%) isolates had intermediate resistance to penicillin, none was highly resistant. Whereas no isolate was resistant to erythromycin, 98.9% were resistant to trimethoprim-sulphamethoxazole (co-trimoxazole). Conclusions: In vitro resistance in S. pneumoniae to co-trimoxazole treatment was high, and the majority of isolates had intermediate resistance to penicillin. To inform treatment policies on the clinical efficacy of current treatment protocols for pneumonia in health facilities and at the community level, routine surveillance of resistance in pneumonia pathogens is needed as well as research on treatment efficacy in cases with resistant strains. Improved clinical algorithms and diagnostics for pneumonia should be developed.
AB - Background: In Uganda, the main causes of death in children under 5 years of age are malaria and pneumonia - often due to delayed diagnosis and treatment. In preparation for a community case management intervention for pneumonia and malaria, the bacterial composition of the nasopharyngeal flora and its in vitro resistance were determined in children aged five or under to establish baseline resistance to commonly used antibiotics. Methods: In a population-based survey in April 2008, nasopharyngeal specimens were collected from 152 randomly selected healthy children under 5 years of age in the Iganga/Mayuge Health and Demographic Surveillance Site (HDSS). Medical history and prior treatment were recorded. Demographic characteristics and risk factors for carriage of resistant strains were obtained from the HDSS census. Bacteria were isolated and analysed for antibiotic susceptibility using disk diffusion and E test. Results: Streptococcus pneumoniae (S. pneumoniae) carriage was 58.6%, and, while most (80.9%) isolates had intermediate resistance to penicillin, none was highly resistant. Whereas no isolate was resistant to erythromycin, 98.9% were resistant to trimethoprim-sulphamethoxazole (co-trimoxazole). Conclusions: In vitro resistance in S. pneumoniae to co-trimoxazole treatment was high, and the majority of isolates had intermediate resistance to penicillin. To inform treatment policies on the clinical efficacy of current treatment protocols for pneumonia in health facilities and at the community level, routine surveillance of resistance in pneumonia pathogens is needed as well as research on treatment efficacy in cases with resistant strains. Improved clinical algorithms and diagnostics for pneumonia should be developed.
KW - Antibiotic resistance
KW - Streptococcus pneumoniae
KW - children
KW - community case management
KW - pneumonia
UR - http://www.scopus.com/inward/record.url?scp=84945448292&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84945448292&partnerID=8YFLogxK
U2 - 10.3109/03009734.2015.1072606
DO - 10.3109/03009734.2015.1072606
M3 - Article
C2 - 26305429
AN - SCOPUS:84945448292
SN - 0300-9734
VL - 120
SP - 249
EP - 256
JO - Upsala Journal of Medical Sciences
JF - Upsala Journal of Medical Sciences
IS - 4
ER -